Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Port

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1997
Conditions of drug delivery within solid tumors, and noninvasive methods for studies in humansR E Port
International Journal of Clinical Pharmacology and Therapeutics|March 31, 2004
Non-parametric mixed effects modeling with NPAG: hematopoietic response to erythropoietin in childrenR E Port
Pediatric Nephrology (Berlin, Germany)|August 13, 2008
Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit?Ruediger E Port, Otto Mehls
Investigational New Drugs|August 2, 2003
Noninvasive methods to study drug distributionRuediger E Port, Walter Wolf
Life Sciences|August 2, 1982
The distribution of copper in neonatal mottled mutant mice after exposure to copper and penicillamineD M Hunt, A E Port
The Biochemical Journal|December 1, 1979
A study of the copper-binding proteins in liver and kidney tissue of neonatal normal and mottled mutant miceA E Port, D M Hunt
Clinical Pharmacology and Therapeutics|May 17, 2012
Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI dataG Z Ferl, R E Port
Life Sciences|April 16, 1979
Trace element binding in the copper deficient mottled mutants in the mouseD M Hunt, A E Port
Clinical Pharmacology and Therapeutics|May 1, 1991
Kinetic modeling of in vivo--nuclear magnetic resonance spectroscopy data: 5-fluorouracil in liver and liver tumorsR E Port, P Bachert, W Semmler
Radiation Research|August 1, 1994
Anticarcinogenic effect of tetrachlorodecaoxide after total-body gamma irradiation in ratsS R Kempf, R E Port, S Ivankovic
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1997
Conditions of drug delivery within solid tumors, and noninvasive methods for studies in humansR E Port
International Journal of Clinical Pharmacology and Therapeutics|March 31, 2004
Non-parametric mixed effects modeling with NPAG: hematopoietic response to erythropoietin in childrenR E Port
Pediatric Nephrology (Berlin, Germany)|August 13, 2008
Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit?Ruediger E Port, Otto Mehls
Investigational New Drugs|August 2, 2003
Noninvasive methods to study drug distributionRuediger E Port, Walter Wolf
Life Sciences|August 2, 1982
The distribution of copper in neonatal mottled mutant mice after exposure to copper and penicillamineD M Hunt, A E Port
The Biochemical Journal|December 1, 1979
A study of the copper-binding proteins in liver and kidney tissue of neonatal normal and mottled mutant miceA E Port, D M Hunt
Clinical Pharmacology and Therapeutics|May 17, 2012
Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI dataG Z Ferl, R E Port
Life Sciences|April 16, 1979
Trace element binding in the copper deficient mottled mutants in the mouseD M Hunt, A E Port
Clinical Pharmacology and Therapeutics|May 1, 1991
Kinetic modeling of in vivo--nuclear magnetic resonance spectroscopy data: 5-fluorouracil in liver and liver tumorsR E Port, P Bachert, W Semmler
Radiation Research|August 1, 1994
Anticarcinogenic effect of tetrachlorodecaoxide after total-body gamma irradiation in ratsS R Kempf, R E Port, S Ivankovic
Pageof 5